Quantitating tissue specificity of human genes to facilitate biomarker discovery

Bioinformatics

Volumn 23, Issue 11, 2007, Pages 1348-1355

  Vasmatzis, George ^a   Klee, Eric W ^a   Kube, Dagmar M ^a   Therneau, Terry M ^b   Kosari, Farhad ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE IDENTIFICATION; GENE NUMBER; GENE SEQUENCE; GENE TARGETING; GENETIC DATABASE; GENOME ANALYSIS; HIGH THROUGHPUT SCREENING; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; VALIDATION STUDY;

EID: 34447320204     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/btm102     Document Type: Article

References (23)

1. Anscombe,F.J. (1949) Transformations of poisson, binomial and negative-binomial data. Biometrika, 35, 246-254.
2. Asmann,Y.W. et al. (2002) Identification of differentially expressed genes in normal and malignant prostate by electronic profiling of expressed sequence tags. Cancer Res., 62, 3308-3314.
3. Bast,R.C., Jr et al. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med., 309, 883-887.
4. Benowitz,S. (2004) Biomarker boom slowed by validation concerns. J. Natl Cancer Inst., 96, 1356-1357.
5. Bon,G.G. et al. (1996) Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values. Am. J. Obstet. Gynecol., 174, 107-114.
6. Eberspaecher,U. et al. (1995) Mouse androgen-depedent epididymal glycoprotein CRISP-1 (DE/AEG): Isolation, biochemical characterization, and expression in recombinant form. Mol. Reprod. Dev., 42, 157-172.
7. Hardardottir,H. et al. (1990) Distribution of CA 125 in embryonic tissues and adult derivatives of the fetal periderm. Am. J. Obstet. Gynecol., 163, 1925-1931.
8. Jongeneel,C.V. et al. (2005) An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res., 15, 1007-1014.
9. Kent,W J. (2002) BLAT-the BLAST-like alignment tool. Genome Res., 12, 656-664.
10. Klee,E.W. et al. (2006) Bioinformatics methods for prioritizing serum biomarker candidates. Clin. Chem., 52, 2162-2164.
11. Lloyd,K.O. and Yin,B.W. (2001) Synthesis and secretion of the ovarian cancer antigen CA 125 by the human cancer cell line NIH:OVCAR-3. Tumour Biol., 22, 77-82.
12. McCullagh,P. and Nelder,J.A. (1983) Generalized Linear Models. Chapman and Hall Ltd, London, England.
13. Meyer,T. and Rustin,G.J. (2000) Role of tumour markers in monitoring epithelial ovarian cancer. Br. J. Cancer, 82, 1535-1538.
14. Nap,M. et al. (1996) Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop. Tumour Biol., 17, 325-331.
15. O'Brien,T.J. et al. (1986) CA 125 antigen in human amniotic fluid and fetal membranes. Am. J. Obstet. Gynecol., 155, 50-55.
16. Su,A.I. et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl Acad. Sci. USA, 101 6062-6067.
17. Ugrinska,A. et al. (2002) Circulating tumor markers and nuclear medicine imaging modalities: Breast, prostate and ovarian cancer. Q. J. Nucl. Med., 46, 88-104.
18. Upasani,O.S. et al. (2004) Database on monoclonal antibodies to cytokeratins. Oral. Oncol., 40, 236-256.
19. Vasmatzis,G. et al. (1998) Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis. Proc. Natl Acad. Sci. USA, 95, 300-304.
20. Velculescu,V.E. et al. (1995) Serial analysis of gene expression. Science, 270, 484-487.
21. Wheeler,D.L. et al. (2003) Database Resources of the National Center for Biotechnology. Nucleic Acids Res., 31, 28-33.
22. Zhang,Y. et al. (2004) GEPIS-quantitative gene expression profiling in normal and cancer tissues. Bioinformatics, 20, 2390-2398.
23. Zurawski,V.R., Jr et al. (1988) An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecol. Oncol., 30, 7-14.